The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
ERBP
10 / 18 results found
Click here to register now!
Speaker
Roland Schmieder, Germany
Panellists
Michel Burnier, Switzerland
Alberto Ortiz, Spain
Moderator
Pantelis Sarafidis, Greece
Wednesday, March 19, 2025, at 5:00 PM (CET)
ERBP
Click here to register now!
Speaker
Charles Ferro, United Kingdom
Panellists
Mehmet Kanbay, Türkiye
Valerie Luyckx, Switzerland
Moderator
Pantelis Sarafidis, Greece
Thursday, November 14, 2024, at 5:00 PM (CET)
ERBP
SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease
Speaker
Patrick Mark, United Kingdom
Panellists
Evangelia Dounousi, Greece
Sokratis Stoumpos, United Kingdom
Moderator
Pantelis Sarafidis, Greece
ERBP